Clene to Present at the Canaccord 45th Annual Growth Conference
SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...
Staff
Senti Bio Determines Recommended Phase 2 Dose (RP2D) in Phase 1 Study of SENTI-202 for the Treatment of Relapsed/Refractory Hematologic Malignancies, Including Acute Myeloid Leukemia
Continued progress positions Company to report topline data for Phase 1 clinical trial of SENTI-202 before year-endSOUTH SAN FRANCISCO, Calif.,...
Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th
MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., Aug....
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
Strengthens Balance Sheet and Continues Commercialization Readiness Plans for the LIBERTY® System as it Nears FDA Marketing Clearance DecisionHINGHAM, Mass.,...
Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced...
Conduit to Change Name to CDT Equity Inc.
Name change to CDT Equity Inc. reflects evolution of strategy and focus on identifying, enhancing, and advancing high-potential therapeutic assets...
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
Acquisition to Include DANYELZA® (Naxitamab-gqgk), Further Broadening SERB’s Rare Oncology Product PortfolioTransaction Expands SERB’s Investment in the U.S.SERB to Commence...
Bioma Probiotics Launches Science-Backed Gut Health Formula for Women’s Natural Weight Loss
Discover how Bioma Probiotics supports weight loss, balances gut health, and helps women reduce bloating, boost energy, and improve digestion...
Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)...
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
IRB Approval from Hadassah Medical Center Follows FDA IND Clearance and Prior Approvals from Additional Clinical Sites Vancouver, Canada, Aug....
Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115
LIBERATE-1, the first-in-human application of Vivani’s NanoPortalTM implant technology, showed a positive safety and tolerability profile, along with encouraging performance...
CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Privately held CHO Plus, Inc. announced today a project agreement...
HOOPP launches 2030 Strategic Plan to build a stronger financial future for Ontario’s healthcare community
Five-year plan seeks to drive member value and portfolio resilienceTORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario...
Republic Technologies Partners with BitGo to Safeguard Ethereum Operations
Vancouver, British Columbia--(Newsfile Corp. - August 5, 2025) - Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM0) (the "Company" or "Republic")...
GRAFAPEX (treosulfan) for Injection Receives CMS Approval of New Technology Add-On Payment (NTAP) for Eligible Cases in CMS’s Fiscal Year 2026
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to...
Axis Research & Technologies Celebrates 10 Years of Innovation and Sets Its Sights on Vision for Building the First AI-Powered Smart Surgical Center
Future Surgical Center to Be Powered by OMNIMED SmartOR™ Technology, Anchored on a World-Class University Campus and Driven by Axis...
Will DEA Cole Dismantle Marijuana Research Blockade – MMJ Biopharma Will Be His First Test Case
Terry Cole's future as DEA Administrator depends on recognizing the difference between cartels trafficking illicit fentanyl and MMJ's BioPharma Cultivation...
BioNxt Solutions Reports Pending Patent Grants in Europe and Eurasia, Strengthening IP Protection for Proprietary Sublingual Cladribine-Based MS Treatment
VANCOUVER, BC / ACCESS Newswire / August 5, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE: BNXT)(OTC PINK:BNXTF)(FSE:BXT), a...
Long Covid Patients Can Sign up for Remote Clinical Trial Notification, Announces CareEvolution
At-home participation in a study by Scripps Research and Schmidt Initiative for Long Covid powered by CareEvolution’s MyDataHelps® platformANN ARBOR,...